Back
Delegates Premium Access

Exercise oscillatory ventilation (EOV) as a predictor of mortality in patients with amyloid cardiomyopathy

Session: Cardiac amyloidosis
Topic: Cardiovascular Disease in the Elderly
Speaker: Doctor R. Willixhofer (Milan, IT)
Event: ESC Preventive Cardiology 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Robin Willixhofer

Monzino Cardiology Centre, Milan (Italy)
0 follower

4 more presentations in this session

Exercise training and Rehabilitation In Cardiac Amyloidosis (ERICA) study: rationale and design

Speaker: Associate Professor A. Marra (Naples, IT)

Access
Abstract
Slides
Like
Thumbnail

Cardiopulmonary exercise testing in cardiac amyloidosis - a systematic review and meta-analysis

Speaker: Doctor R. Willixhofer (Milan, IT)

Access
Abstract
Slides
Like
Thumbnail

Association of body mass index with outcomes in patients with amyloid cardiomyopathy

Speaker: Doctor N. Ermolaev (Vienna, AT)

Access
Abstract
Slides
Like
Thumbnail

NT-proBNP and cardiopulmonary exercise testing parameters for risk stratification in ATTR-CM

Speaker: Mr B. Gregshammer (Vienna, AT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Cardiac amyloidosis

Speakers: Doctor R. Willixhofer, Associate Professor A. Marra, Doctor R. Willixhofer, Doctor N. Ermolaev, Mr B. Gregshammer
Access
Like
Thumbnail

About the event

Image

ESC Preventive Cardiology 2025

3 April - 5 April 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources